Further Investigations on Natural and Synthetic Bis-(1,2,3,4-tetrahydroisoquinoline) Derivatives Interacting with the Apamin-Sensitive Site of Small-Conductance Calcium-Activated Potassium Channels. - 2026
Further Investigations on Natural and Synthetic Bis-(1,2,3,4-tetrahydroisoquinoline) Derivatives Interacting with the Apamin-Sensitive Site of Small-Conductance Calcium-Activated Potassium Channels.
[en] Our previous study demonstrated that bis-(1,2,3,4-tetrahydroisoquinoline) (bis-THIQ) compounds such as tetrandrine and AG525E1 exhibit significant affinity for SK channels. Interestingly, the stereoisomers of AG525 display markedly different affinities toward SK channels, with the (S,S) stereoisomer being the best ligand. Previous structure-based in silico investigations failed to provide a satisfactory explanation for these differences. Moreover, a series of simplified THIQ derivatives derived from AG525 showed little or no affinity for SK channels, raising questions about the structural features required for binding to SK channels. To better understand the structure-activity relationships within this chemical family with diverse three-dimensional features, a ligand-based approach is developed in this work. Using a dataset composed of AG525 stereoisomers and natural bis-THIQ derivatives, a pharmacophore model was generated to identify key molecular features required for binding to SK channels and to rationalize the observed differences in activity. Twenty pharmacophore hypotheses were generated, with the best-ranked models highlighting five major interaction features: an aromatic ring, one acceptor group associated with this ring, one lipophilic feature, one positive charge, and a second acceptor site located farther from the THIQ moiety. This model differs from previously proposed pharmacophores emphasizing the presence of two positive charges. Two alkaloids recently identified as SK channel ligands, (1) and (2), were found to match all five pharmacophoric features despite not being included in the training set. The absence of SK affinity of a series of simplified THIQ analogues derived from AG525 could be explained using the model. To go further, the predictive value of the model was evaluated by evaluating in silico the propensity of a series of cyclic and non-cyclic bis-THIQ alkaloids to bind to SK channels. High fitting scores were obtained for these compounds, and subsequent in vitro experiments, using radioligand competitive binding assays, were performed and confirmed that they belong as ligands.
Research Center/Unit :
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège
Disciplines :
Pharmacy, pharmacology & toxicology Chemistry
Author, co-author :
Taouba, Hossein ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Vitello, Romain ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Pereira Barbon, Donna; Laboratory of Medicinal Chemistry, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, 4000 Liège, Belgium
Hayen, Jean-Luc ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Herbet, Coralie ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Falinski, Szymon Piotr ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Tumanov, Nikolay ; Namur Institute of Structured Matter (NISM) and Namur Research Institute for Life Sciences (NARILIS) Research Institutes, Department of Chemistry, University of Namur, 5000 Namur, Belgium
Wouters, Johan ; Namur Institute of Structured Matter (NISM) and Namur Research Institute for Life Sciences (NARILIS) Research Institutes, Department of Chemistry, University of Namur, 5000 Namur, Belgium
Liégeois, Jean-François ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Language :
English
Title :
Further Investigations on Natural and Synthetic Bis-(1,2,3,4-tetrahydroisoquinoline) Derivatives Interacting with the Apamin-Sensitive Site of Small-Conductance Calcium-Activated Potassium Channels.
Publication date :
05 August 2026
Journal title :
Molecules
eISSN :
1420-3049
Publisher :
Multidisciplinary Digital Publishing Institute (MDPI), Switzerland
Fonds de la Recherche Scientifique de Belgique Fonds de la Recherche Scientifique de Belgique Fédération Wallonie-Bruxelles
Funding text :
This work was supported by a Research Credit grant 353230060 and a Televie grant 40002303 from Fonds de la Recherche Scientifique de Belgique (F.R.S.)-FNRS, Research credit from the \u00AB Fondation L\u00E9on Fredericq \u00BB ULi\u00E8ge, and an \u201CAction de Recherche Concert\u00E9e\u201D from F\u00E9d\u00E9ration Wallonie-Bruxelles (grant ARC 21/25-08).
Bailly C. Cepharanthine: An update of its mode of action, pharmacological properties and medical applications Phytomedicine 2019 62 152956 10.1016/j.phymed.2019.152956 31132753
Ichikawa K. Johnson H.M. Curtis M.A. Biswas N. Singh S. Khachatryan H.N. Gater A.E. Lin S.X. Sperry J. Targeting glioma with heteroaromatic alkaloids: A review of potential therapeutics Bioorg. Med. Chem. 2025 121 118051 10.1016/j.bmc.2024.118051 39999647
Vitello R. Taouba H. Derand M. Liégeois J.-F. The Bis(1,2,3,4-tetrahydroisoquinoline) Alkaloids Cepharanthine and Berbamine Are Ligands of SK Channels ACS Med. Chem. Lett. 2024 15 215 220 Correction in ACS Med. Chem. Lett. 2025, 16, 2355–2356. https://doi.org/10.1021/acsmedchemlett.5c00618 10.1021/acsmedchemlett.3c00452 38352826
Vitello R. Towards Better SK Tools: Improving the SK Pharmacophore Model Ph.D. Thesis University of Liège Liège, Belgium 2025
Pedarzani P. McCutcheon J.E. Rogge G. Jensen B.S. Christophersen P. Hougaard C. Strøbaek D. Stocker M. Specific enhancement of SK channel activity selectively potentiates the afterhyperpolarizing current I(AHP) and modulates the firing properties of hippocampal pyramidal neurons J. Biol. Chem. 2005 280 41404 41411 10.1074/jbc.M509610200 16239218
Diness J.G. Sørensen U.S. Nissen J.D. Al-Shahib B. Jespersen T. Grunnet M. Hansen R.S. Inhibition of small-conductance Ca2+-activated K+ channels terminates and protects against atrial fibrillation Circ. Arrhythmia Electrophysiol. 2010 3 380 390 10.1161/CIRCEP.110.957407 20562443
Galeotti N. Ghelardini C. Caldari B. Bartolini A. Effect of potassium channel modulators in mouse forced swimming test Br. J. Pharmacol. 1999 126 1653 1659 10.1038/sj.bjp.0702467 10323599
Sargin D. Oliver D.K. Lambe E.K. Chronic social isolation reduces 5-HT neuronal activity via upregulated SK3 calcium-activated potassium channels eLife 2016 5 e21416 10.7554/eLife.21416 27874831
Chantôme A. Potier-Cartereau M. Clarysse L. Fromont G. Marionneau-Lambot S. Guéguinou M. Pagès J.-C. Collin C. Oullier T. Girault A. et al. Pivotal Role of the Lipid Raft SK3–Orai1 Complex in Human Cancer Cell Migration and Bone Metastases Cancer Res. 2013 73 4852 4861 10.1158/0008-5472.CAN-12-4572 23774210
Romito O. Lemettre A. Chantôme A. Champion O. Couty N. Ouldamer L. Hempel N. Trebak M. Goupille C. Potier-Cartereau M. Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high-grade serous ovarian cancer cells Mol. Oncol. 2024 18 1853 1865 10.1002/1878-0261.13631 38480668
Tajima N. Schönherr K. Niedling S. Kaatz M. Kanno H. Schönherr R. Heinemann S.H. Ca2+-activated K+ channels in human melanoma cells are up-regulated by hypoxia involving hypoxia-inducible factor-1α and the von Hippel-Lindau protein J. Physiol. 2006 571 349 359 10.1113/jphysiol.2005.096818 16396931
Potier M. Joulin V. Roger S. Besson P. Jourdan M.-L. LeGuennec J.-Y. Bougnoux P. Vandier C. Identification of SK3 channel as a new mediator of breast cancer cell migration Mol. Cancer Ther. 2006 5 2946 2953 10.1158/1535-7163.MCT-06-0194 17121942
Ma B. Wu D. Cao E. Chi C. Wang Z. Xia Z. Sun L.-H. Pan B. Jiang D. Zhang W. Structural mechanisms for inhibition and activation of human small-conductance Ca2+-activated potassium channel SK2 Nat. Commun. 2026 17 1770 10.1038/s41467-026-68475-4 41540047
Diness J.G. Kirchhoff J.E. Speerschneider T. Abildgaard L. Edvardsson N. Sørensen U.S. Grunnet M. Bentzen B.H. The KCa2 Channel Inhibitor AP30663 Selectively Increases Atrial Refractoriness, Converts Vernakalant-Resistant Atrial Fibrillation and Prevents Its Reinduction in Conscious Pigs Front. Pharmacol. 2020 11 159 10.3389/fphar.2020.00159 32180722
Yfanti C. Vestbjerg B. Van’T Westende J. Edvardsson N. Monfort L.M. Olesen M.S. Bentzen B.H. Grunnet M. Eveleens Maarse B.C. Diness J.G. et al. A phase 1 trial of AP30663, a KCa 2 channel inhibitor in development for conversion of atrial fibrillation Br. J. Clin. Pharmacol. 2024 90 1027 1035 10.1111/bcp.15973 37990600
Holst A.G. Tomcsányi J. Vestbjerg B. Grunnet M. Sørensen U.S. Diness J.G. Bentzen B.H. Edvardsson N. Hohnloser S.H. Bhatt D.L. et al. Inhibition of the KCa2 potassium channel in atrial fibrillation: A randomized phase 2 trial Nat. Med. 2024 30 106 111 10.1038/s41591-023-02679-9 38092897
Hugues M. Romey G. Duval D. Vincent J.P. Lazdunski M. Apamin as a selective blocker of the calcium-dependent potassium channel in neuroblastoma cells: Voltage-clamp and biochemical characterization of the toxin receptor Proc. Natl. Acad. Sci. USA 1982 79 1308 1312 10.1073/pnas.79.4.1308 6122211
Blatz A.L. Magleby K.L. Single apamin-blocked Ca-activated K+ channels of small conductance in cultured rat skeletal muscle Nature 1986 323 718 720 10.1038/323718a0 2430185
Kuzmenkov A.I. Peigneur S. Nasburg J.A. Mineev K.S. Nikolaev M.V. Pinheiro-Junior E.L. Arseniev A.S. Wulff H. Tytgat J. Vassilevski A.A. Apamin structure and pharmacology revisited Front. Pharmacol. 2022 13 977440 10.3389/fphar.2022.977440 36188602
Callewaert G.L. Shipolini R. Vernon C.A. The disulphide bridges of apamin FEBS Lett. 1968 1 111 113 10.1016/0014-5793(68)80033-X 11945268
Dempsey C.E. Sessions R.B. Lamble N.V. Campbell S.J. The Asparagine-Stabilized β-Turn of Apamin: Contribution to Structural Stability from Dynamics Simulation and Amide Hydrogen Exchange Analysis Biochemistry 2000 39 15944 15952 10.1021/bi002044q 11123921
Lamy C. Goodchild S.J. Weatherall K.L. Jane D.E. Liégeois J.-F. Seutin V. Marrion N.V. Allosteric Block of KCa2 Channels by Apamin* J. Biol. Chem. 2010 285 27067 27077 10.1074/jbc.M110.110072 20562108
Weatherall K.L. Seutin V. Liégeois J.-F. Marrion N.V. Crucial role of a shared extracellular loop in apamin sensitivity and maintenance of pore shape of small-conductance calcium-activated potassium (SK) channels Proc. Natl. Acad. Sci. USA 2011 108 18494 18499 10.1073/pnas.1110724108 22025703
Nam Y.-W. Im D. Garcia A.S.C. Tringides M.L. Nguyen H.M. Liu Y. Orfali R. Ramanishka A. Pintilie G. Su C.-C. et al. Cryo-EM structures of the small-conductance Ca2+-activated KCa2.2 channel Nat. Commun. 2025 16 3690 10.1038/s41467-025-59061-1 40246884
Cassell S.J. Li W. Krautwald S. Khoshouei M. Lee Y.T. Hou J. Guan W. Peukert S. Weihofen W.A. Whicher J.R. Mechanism of SK2 channel gating and its modulation by the bee toxin apamin and small molecules eLife 2025 14 RP107733 10.7554/eLife.107733.2
Finlayson K. McLuckie J. Hern J. Aramori I. Olverman H.J. Kelly J.S. Characterisation of [125I] -apamin binding sites in rat brain membranes and HEK293 cells transfected with SK channel subtypes Neuropharmacology 2001 41 341 350 10.1016/S0028-3908(01)00067-3 11522325
Graulich A. Mercier F. Scuvée-Moreau J. Seutin V. Liégeois J.-F. Synthesis and biological evaluation of N-methyl-laudanosine iodide analogues as potential SK channel blockers Bioorg. Med. Chem. 2005 13 1201 1209 10.1016/j.bmc.2004.11.025 15670929
Oller-Salvia B. Sánchez-Navarro M. Ciudad S. Guiu M. Arranz-Gibert P. Garcia C. Gomis R.R. Cecchelli R. García J. Giralt E. et al. MiniAp-4: A Venom-Inspired Peptidomimetic for Brain Delivery Angew. Chem. Int. Ed. 2016 55 572 575 10.1002/anie.201508445 26492861
Brasnjevic I. Steinbusch H.W.M. Schmitz C. Martinez-Martinez P. Delivery of peptide and protein drugs over the blood–brain barrier Prog. Neurobiol. 2009 87 212 251 10.1016/j.pneurobio.2008.12.002 19395337
Craik D.J. Fairlie D.P. Liras S. Price D. The Future of Peptide-based Drugs Chem. Biol. Drug Des. 2013 81 136 147 10.1111/cbdd.12055 23253135
Rosa J.C. Galanakis D. Ganellin C.R. Dunn P.M. Jenkinson D.H. Bis-Quinolinium Cyclophanes: 6,10-Diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the First Nanomolar, Non-Peptidic Blocker of the Apamin-Sensitive Ca2+-Activated K+ Channel J. Med. Chem. 1998 41 2 5 10.1021/jm970571a 9438015
Seutin V. Scuvée-Moreau J. Dresse A. Evidence for a non-GABAergic action of quaternary salts of bicuculline on dopaminergic neurones Neuropharmacology 1997 36 1653 1657 10.1016/S0028-3908(97)00147-0 9517436
Scuvée-Moreau J. Liégeois J.-F. Massotte L. Seutin V. Methyl-Laudanosine: A New Pharmacological Tool to Investigate the Function of Small-Conductance Ca2+-Activated K+Channels J. Pharmacol. Exp. Ther. 2002 302 1176 1183 10.1124/jpet.302.3.1176 12183678
Graulich A. Lamy C. Alleva L. Dilly S. Chavatte P. Wouters J. Seutin V. Liégeois J.-F. Bis-tetrahydroisoquinoline derivatives: AG525E1, a new step in the search for non-quaternary non-peptidic small conductance Ca2+-activated K+ channel blockers Bioorg. Med. Chem. Lett. 2008 18 3440 3445 10.1016/j.bmcl.2008.03.069 18436444
Liégeois J.-F. Wouters J. Seutin V. Dilly S. Bis-(1,2,3,4-tetrahydroisoquinolinium): A Chiral Scaffold for Developing High-Affinity Ligands for SK Channels ChemMedChem 2014 9 737 740 10.1002/cmdc.201400028 24829978
Neny M. Lemmer Y. Graulich A. Alleva L. Piazza P.V. Seutin V. Spampinato U. Liégeois J.-F. The SK channel blocker AG525E1 increases locomotor activity and in vivo dopamine release in the rat nucleus accumbens Monitoring Molecules in Neuroscience—Proceedings of the 12th International Conference on In Vivo Methods Phillips P.E.M. Sandberg S.G. Ahn S. Phillips A.G. University of British Columbia Vancouver, BC, Canada 2008 267 270
Tighilet B. Bourdet A. Péricat D. Timon-David E. Rastoldo G. Chabbert C. SK Channels Modulation Accelerates Equilibrium Recovery in Unilateral Vestibular Neurectomized Rats Pharmaceuticals 2021 14 1226 10.3390/ph14121226 34959626
Dilly S. Graulich A. Farce A. Seutin V. Liegeois J.-F. Chavatte P. Identification of a pharmacophore of SKCa channel blockers J. Enzym. Inhib. Med. Chem. 2005 20 517 523 10.1080/14756360500210989 16408787
Graulich A. Dilly S. Farce A. Scuvée-Moreau J. Waroux O. Lamy C. Chavatte P. Seutin V. Liégeois J.-F. Synthesis and Radioligand Binding Studies of Bis-isoquinolinium Derivatives as Small Conductance Ca2+-Activated K+ Channel Blockers J. Med. Chem. 2007 50 5070 5075 10.1021/jm070412j 17867663
Graulich A. Scuvée-Moreau J. Liégeois J.-F. Synthesis and radioligand binding studies of C-5- and C-8-Substituted 1-(3,4-Dimethoxybenzyl)-2,2-dimethyl-1,2,3,4-tetrahydroisoquinoliniums as SK channel blockers related to N-Methyl-laudanosine and N-Methyl-noscapine J. Med. Chem. 2005 48 4972 4982 10.1021/jm049025p 16033276
Graulich A. Scuvée-Moreau J. Alleva L. Lamy C. Waroux O. Seutin V. Liégeois J.-F. Synthesis and Radioligand Binding Studies of Methoxylated 1,2,3,4-Tetrahydroisoquinolinium Derivatives as Ligands of the Apamin-Sensitive Ca2+-Activated K+ Channels J. Med. Chem. 2006 49 7208 7214 10.1021/jm0607395 17125273
Wouters J. Elasaad K. Norberg B. Graulich A. Liégeois J.-F. Bis-tetrahydroisoquinoline derivatives: Structure analysis of the three stereoisomers of 1,1′-(propane-1,3-diyl)-bis-(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline) Eur. J. Med. Chem. 2010 45 3240 3244 10.1016/j.ejmech.2010.03.020 20381214
Wang L. Pu Z. Li M. Wang K. Deng L. Chen W. Antioxidative and antiapoptosis: Neuroprotective effects of dauricine in Alzheimer’s disease models Life Sci. 2020 243 117237 10.1016/j.lfs.2019.117237 31887302
Park H.-J. Gholam Zadeh M. Suh J.-H. Choi H.-S. Dauricine Protects from LPS-Induced Bone Loss via the ROS/PP2A/NF-κB Axis in Osteoclasts Antioxidants 2020 9 588 10.3390/antiox9070588 32640590
Qiao B. Wang H. Wang C. Liang M. Huang K. Li Y. Dauricine negatively regulates lipopolysaccharide- or cecal ligation and puncture-induced inflammatory response via NF-κB inactivation Arch. Biochem. Biophys. 2019 666 99 106 10.1016/j.abb.2019.03.018 30946805
Yang X.-Y. Jiang S.-Q. Zhang L. Liu Q.-N. Gong P.-L. Inhibitory Effect of Dauricine on Inflammatory Process Following Focal Cerebral Ischemia/Reperfusion in Rats Am. J. Chin. Med. 2007 35 477 486 10.1142/S0192415X07004990 17597506
Yang Z. Li C. Wang X. Zhai C. Yi Z. Wang L. Liu B. Du B. Wu H. Guo X. et al. Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-κB signaling pathway in colon cancer cells J. Cell. Physiol. 2010 225 266 275 10.1002/jcp.22261 20509140
Liu Y. Wang C. Liao Q. Du C. Pharmacological Potential and Mechanisms of Bisbenzylisoquinoline Alkaloids from Lotus Seed Embryos Biomolecules 2025 15 1377 10.3390/biom15101377 41154606
Kadioglu O. Law B.Y.K. Mok S.W.F. Xu S.-W. Efferth T. Wong V.K.W. Mode of Action Analyses of Neferine, a Bisbenzylisoquinoline Alkaloid of Lotus (Nelumbo nucifera) against Multidrug-Resistant Tumor Cells Front. Pharmacol. 2017 8 238 10.3389/fphar.2017.00238 28529482
Manogaran P. Beeraka N.M. Huang C.-Y. Vijaya Padma V. Neferine and isoliensinine enhance ‘intracellular uptake of cisplatin’ and induce ‘ROS-mediated apoptosis’ in colorectal cancer cells—A comparative study Food Chem. Toxicol. 2019 132 110652 10.1016/j.fct.2019.110652 31255669
Guo Z. Wu M. Chen L. Chen H. Wu J. Xie Q. Lin G. Lian D. Peng J. Shen A. Neferine attenuates hypertensive cardiomyocyte apoptosis and modulates key signaling pathways: An in vivo and in vitro study Eur. J. Pharmacol. 2025 994 177393 10.1016/j.ejphar.2025.177393 39956263
Cheng Y. Li H.-L. Zhou Z.-W. Long H.-Z. Luo H.-Y. Wen D.-D. Cheng L. Gao L.-C. Isoliensinine: A Natural Compound with “Drug-Like” Potential Front. Pharmacol. 2021 12 630385 10.3389/fphar.2021.630385 33967765
Jung Y.Y. Shanmugam M.K. Chinnathambi A. Alharbi S.A. Shair O.H.M. Um J.-Y. Sethi G. Ahn K.S. Fangchinoline, a Bisbenzylisoquinoline Alkaloid can Modulate Cytokine-Impelled Apoptosis via the Dual Regulation of NF-κB and AP-1 Pathways Molecules 2019 24 3127 10.3390/molecules24173127 31466313
Xing Z. Zhang Y. Zhang X. Yang Y. Ma Y. Pang D. Fangchinoline Induces G1 Arrest in Breast Cancer Cells Through Cell-Cycle Regulation Phytother. Res. 2013 27 1790 1794 10.1002/ptr.4936 23401195
Yang S. Yang X. Wang Z. Li W. Cao R. Zhong W. Fangchinoline Inhibits Zika Virus by Disrupting Virus Internalization ACS Infect. Dis. 2024 10 4066 4072 10.1021/acsinfecdis.4c00600 39534987
Martínez J. Bello A. Rubio L. Rodríguez C. Galán L. Caudales E. Alvarez J. Calcium antagonist properties of the bisbenzylisoquinoline alkaloid cycleanine Fundam. Clin. Pharmacol. 1998 12 182 187 10.1111/j.1472-8206.1998.tb00939.x 9565772
Nwaefulu O.N. Al-Shar’i N.A. Owolabi J.O. Sagineedu S.R. Woei L.C. Wai L.K. Islam M.K. Jayanthi S. Stanslas J. The impact of cycleanine in cancer research: A computational study J. Mol. Model. 2022 28 340 10.1007/s00894-022-05326-1 36194315
Uche F.I. Guo X. Okokon J. Ullah I. Horrocks P. Boateng J. Huang C. Li W.-W. In Vivo Efficacy and Metabolism of the Antimalarial Cycleanine and Improved In Vitro Antiplasmodial Activity of Semisynthetic Analogues Antimicrob. Agents Chemother. 2021 65 e01995-20 10.1128/AAC.01995-20 33257443
Galanakis D. Ganellin C.R. Chen J.-Q. Gunasekera D. Dunn P.M. Bis-quinolinium cyclophanes: Toward a pharmacophore model for the blockade of apamin-sensitive SKCa channels in sympathetic neurons Bioorg. Med. Chem. Lett. 2004 14 4231 4235 10.1016/j.bmcl.2004.06.011 15261276
Guha K.P. Mukherjee B. Mukherjee R. Bisbenzylisoquinoline Alkaloids—A Review J. Nat. Prod. 1979 42 1 84 10.1021/np50001a001 27652691
Shamma M. The bisbenzylisoquinoline alkaloids The Isoquinoline Alkaloids: Chemistry and Pharmacology Academic Press New York, NY, USA London, UK 1972 115 132
Schiff P.L. The Bisbenzylisoquinoline Alkaloids—A Tabular Review Alkaloids: Chemical and Biological Perspectives Elsevier Amsterdam, The Netherlands 1999 Volume 14 1 284
Wei H. Han Y. Wang J. Hou T. Yao Y. Jin J. Zhao T. Zhang X. Liu Y. Liang X. Analgesic bisbenzylisoquinoline alkaloids from the rhizoma of Menispermum dauricum DC Bioorg. Chem. 2021 107 104517 10.1016/j.bioorg.2020.104517 33280831
Schütz R. Meixner M. Antes I. Bracher F. A modular approach to the bisbenzylisoquinoline alkaloids tetrandrine and isotetrandrine Org. Biomol. Chem. 2020 18 3047 3068 10.1039/D0OB00078G 32091528
Shah M. Haylett D.G. The pharmacology of hSK1 Ca2+-activated K+ channels expressed in mammalian cell lines Br. J. Pharmacol. 2000 129 627 630 10.1038/sj.bjp.0703111 10683185
Castle N.A. Haylett D.G. Morgan J.M. Jenkinson D.H. Dequalinium: A potent inhibitor of apamin-sensitive K+ channels in hepatocytes and of nicotinic responses in skeletal muscle Eur. J. Pharmacol. 1993 236 201 207 10.1016/0014-2999(93)90590-e 8100530
Weber C. Opatz T. Bisbenzylisoquinoline Alkaloids The Alkaloids: Chemistry and Biology Elsevier Amsterdam, The Netherlands 2019 Volume 81 1 114
Schiff P.L. Jr. Bisbenzylisoquinoline Alkaloids J. Nat. Prod. 1987 50 529 599 10.1021/np50052a001 3323421
Ishii T.M. Maylie J. Adelman J.P. Determinants of Apamin and d-Tubocurarine Block in SK Potassium Channels J. Biol. Chem. 1997 272 23195 23200 10.1074/jbc.272.37.23195 9287325
Liégeois J.F. Mercier F. Graulich A. Graulich-Lorge F. Scuvee-Moreau J. Seutin V. Modulation of Small Conductance Calcium-Activated Potassium (SK) Channels: A New Challenge in Medicinal Chemistry Curr. Med. Chem. 2003 10 625 647 10.2174/0929867033457908 12678783
Cheng Y.-C. Prusoff W.H. Relationship between the inhibition constant (&) and the concentration of inhibitor which causes 50 percent inhibition (Iso) of an enzymatic reaction Biochem. Pharmacol. 1973 22 3099 3108 4202581
Dixon S.L. Smondyrev A.M. Rao S.N. PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching Chem. Biol. Drug Des. 2006 67 370 372 10.1111/j.1747-0285.2006.00384.x 16784462